These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 14732730)
1. Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Ito K; Hirooka Y; Kishi T; Kimura Y; Kaibuchi K; Shimokawa H; Takeshita A Hypertension; 2004 Feb; 43(2):156-62. PubMed ID: 14732730 [TBL] [Abstract][Full Text] [Related]
2. Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Ito K; Hirooka Y; Sakai K; Kishi T; Kaibuchi K; Shimokawa H; Takeshita A Circ Res; 2003 Jun; 92(12):1337-43. PubMed ID: 12791705 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition. Eshima K; Hirooka Y; Shigematsu H; Matsuo I; Koike G; Sakai K; Takeshita A Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of rho-kinase in the nucleus tractus solitarius enhances glutamate sensitivity in rats. Ito K; Hirooka Y; Hori N; Kimura Y; Sagara Y; Shimokawa H; Takeshita A; Sunagawa K Hypertension; 2005 Aug; 46(2):360-5. PubMed ID: 16051902 [TBL] [Abstract][Full Text] [Related]
5. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192 [TBL] [Abstract][Full Text] [Related]
6. Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats. Ito K; Hirooka Y; Kimura Y; Shimokawa H; Takeshita A Clin Exp Hypertens; 2005; 27(2-3):269-77. PubMed ID: 15835390 [TBL] [Abstract][Full Text] [Related]
7. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Chrissobolis S; Sobey CG Circ Res; 2001 Apr; 88(8):774-9. PubMed ID: 11325868 [TBL] [Abstract][Full Text] [Related]
8. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery. Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942 [TBL] [Abstract][Full Text] [Related]
9. Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors. Sagara Y; Hirooka Y; Nozoe M; Ito K; Kimura Y; Sunagawa K J Hypertens; 2007 Feb; 25(2):399-406. PubMed ID: 17211247 [TBL] [Abstract][Full Text] [Related]
10. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888 [TBL] [Abstract][Full Text] [Related]
11. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats. Rajasekaran M; Wilkes N; Kuntz S; E Albo M Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631 [TBL] [Abstract][Full Text] [Related]
12. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats. Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220 [TBL] [Abstract][Full Text] [Related]
13. Ovariectomy augments hypertension through rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Ito K; Hirooka Y; Kimura Y; Sagara Y; Sunagawa K Hypertension; 2006 Oct; 48(4):651-7. PubMed ID: 16940229 [TBL] [Abstract][Full Text] [Related]
14. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo. Chrissobolis S; Budzyn K; Marley PD; Sobey CG Stroke; 2004 Sep; 35(9):2200-5. PubMed ID: 15256679 [TBL] [Abstract][Full Text] [Related]
15. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335 [TBL] [Abstract][Full Text] [Related]
17. In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Huang HN; Lu PJ; Lo WC; Lin CH; Hsiao M; Tseng CJ Circulation; 2004 Oct; 110(16):2476-83. PubMed ID: 15466647 [TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155 [TBL] [Abstract][Full Text] [Related]
19. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129 [TBL] [Abstract][Full Text] [Related]
20. Rho-kinase contributes to hypoxia/reoxygenation-induced cerebral endothelial dysfunction. Xie H; Ray PE; Short BL J Cardiovasc Pharmacol; 2006 Jul; 48(1):814-9. PubMed ID: 16891909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]